Overview
- Five pediatric leukemia patients who received intrathecal anticancer injections developed neurological symptoms, one male patient in his teens later died and two others became critically ill.
- The hospital reported the cluster to Saitama Prefectural Police on March 10 after its internal review raised the possibility of both accident and criminal factors.
- On May 27 the center convened an external medical-accident investigation committee made up of outside experts to examine causes and to recommend measures to prevent recurrence.
- The committee’s investigation so far has not identified a definitive cause and is focused on how prohibited or wrong liquids may have entered the treatment process and on tightening safeguards for high-risk intrathecal drug administration.
- The case has put patient safety practices under scrutiny, could prompt concrete changes to hospital protocols and oversight, and has deep human consequences for the affected families and for public trust in pediatric cancer care.